Steve Oldham, vice president of law and ethics compliance, general counsel and secretary of Roche Diagnostics Corp., is set to retire after more than three decades in the legal department of one of the world’s largest biotech companies, according to a Roche spokesman.

With Oldham slated to retire on April 30, Roche, a multinational Swiss pharmaceutical and medical device company, is on the hunt for his successor.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]